Treatment with cationic liposome-DNA complexes (CLDCs) protects mice from lethal Western equine encephalitis virus (WEEV) challenge

Antiviral Res. 2010 Aug;87(2):195-203. doi: 10.1016/j.antiviral.2010.04.013. Epub 2010 May 7.

Abstract

Having recently characterized a CD-1 outbred mouse model of pathogenesis for Western equine encephalitis virus, we examined the possible protective effects of cationic liposome-DNA complexes (CLDCs) against encephalitic arboviral infection. In this investigation, mice were pre-treated, co-treated, or post-treated with CLDC then challenged with a subcutaneous or aerosol dose of the highly virulent WEEV-McMillan strain, lethal in mice 4-5 days after inoculation. Pre-treatment with CLDCs provided a significant protective effect in mice, which was reflected in significantly increased survival rates. Further, in some instances a therapeutic effect of CLDC administration up to 12h after WEEV challenge was observed. Mice treated with CLDC had significantly increased serum IFN-gamma, TNF-alpha, and IL-12, suggesting a strong Th1-biased antiviral activation of the innate immune system. In virus-infected animals, large increases in production of IFN-gamma, TNF-alpha, MCP-1, IL-12, and IL-10 in the brain were observed by 72h after infection, consistent with neuroinvasion and viral replication in the CNS. These results indicate that strong non-specific activation of innate immunity with an immune therapeutic such as CLDC is capable of eliciting significant protective immunity against a rapidly lethal strain of WEEV and suggest a possible prophylactic option for exposed individuals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood / immunology
  • Brain / immunology
  • Cytokines / analysis
  • Cytokines / blood
  • DNA / administration & dosage*
  • Disease Models, Animal
  • Drug Carriers / administration & dosage
  • Encephalitis Virus, Western Equine / genetics
  • Encephalitis Virus, Western Equine / immunology*
  • Encephalomyelitis, Equine / drug therapy*
  • Encephalomyelitis, Equine / immunology
  • Encephalomyelitis, Equine / prevention & control*
  • Female
  • Immunologic Factors / administration & dosage*
  • Immunotherapy / methods*
  • Liposomes / administration & dosage*
  • Mice
  • Survival Analysis

Substances

  • Cytokines
  • Drug Carriers
  • Immunologic Factors
  • Liposomes
  • DNA